{"name":"Navitas Pharma","slug":"navitas-pharma","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxOQkRIekt5RkkyRlM4T2FHVUpvOTd4eXRTS2pQRG5tV3RGRGxMNmhfeG1CTFpGaHRRQ1NUOTJNNXZTX18zYUh0VGdoNzRvalk0Q3B4YjhhQk9TM01MODV6NlRjQlAxTktlalBMd0VOUERPOVRPd2ZEbWk4X3dmSk9oT1hKSFZ0WnNwaVl4Zm1lYw?oc=5","date":"2025-10-19","type":"pipeline","source":"The Motley Fool","summary":"3 Growth Stocks to Invest $1,000 in Right Now - The Motley Fool","headline":"3 Growth Stocks to Invest $1,000 in Right Now","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQTjh6UmNQRFRQcWNsQkFRS1pkZGVBSzFkQmtTdWNTNTBPelR4Rkc4OEdYTEl0Y0syM054cmFQbnl5NllyRTRnTWJpcE1KZ3d4X2x0Qk9CeVREa0ZmRUp2bmNiemNqTlFDNU1naXVRNmUxbmZyOVZUMDRhOXRiekxieTVEZ2hGRVJLdkpEZFdmclNYdnN0b2JhX1A2VWdneG9PZlEw?oc=5","date":"2025-10-02","type":"trial","source":"newswire.com","summary":"Navitas Life Sciences Named a Major Contender in Everest Group Clinical Data Management Operations PEAK Matrix(R) Assessment 2025 - newswire.com","headline":"Navitas Life Sciences Named a Major Contender in Everest Group Clinical Data Management Operations PEAK Matrix(R) Assess","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxPWXZyRGdybnA5RGxNajBabGNIUWo4ekp6cGVFUHQtcmdPdUxwbU1xOE96UjdNblpsYU5ybDJMUnlscGVob2k1US1paUU2TVlrTWVUTTBxV1dlLTNDNS0tNUlhZjVDZDE1eGJZeXBsVzIwc2NLUjJ3bTBuQjFKTVpkS1NQUDgyTU1hcmptM24zUmRacTNGQWVseWtuaXhDUkJIUjlQZFRwbG1HYjFOTmtfRDVqd3JKbnhZdy1xbG9aT3FzaXhkVlVtT01KWW1CWms?oc=5","date":"2025-03-13","type":"deal","source":"Novartis","summary":"Novartis named first-ever corporate pharmaceutical partner of the National Football League - Novartis","headline":"Novartis named first-ever corporate pharmaceutical partner of the National Football League","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQdGhMXzVmamdzRk5ZalpDUExJMlhmaS1fNVpHcUlTSEs0eE9KNmZYY3BNRGRMdUc4NmRUaElPWDJtYXRjVGllMWowNWpCQ1lrc0hkODIxQzZEUHliVXd1akJwYWVXZmRYQ2VkMGVGdGVTU2tSU1R4VlZPZWU3NkEzMDRjR29rNDJ6aWY5ZWZOOG5PcWJlV3Nfem82aFdnU1djZDlWdNIBqgFBVV95cUxNYWVUNlp5YVBvWGk5a2RmSEVaeEdmSWxmbUowY2ZrdndxOHVjaDhCenZkLTZRRDRlcG1HWWp2ZTk2Rk9pd1E3b2MyODZhQXRianNBMWZxZDIwbFgxZlNhOS1MLTBNX2QtNVNtRFdfWTZock9MYjBFWFU3WXBfSmVabkRIdlZ3S3RrbGtBa29RU01CQTdvdm8xSTJmV1hvVGZVbkZydGNob2ZZdw?oc=5","date":"2024-12-31","type":"pipeline","source":"Express Pharma","summary":"Mr Anand Rao C, VP - Quality Assurance, Navitas Life Science - Express Pharma","headline":"Mr Anand Rao C, VP - Quality Assurance, Navitas Life Science","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxPN1lYUFctb0I1d2t5MGNDdjcxOUF0UUM2SEZIMnFJZ3RhR3ZMMnYxMElkcTRrTHNOTGVLcWpST0U4N0lHOGxsV3pEdUNDT24xbmhhYXIxTks0UllfRXZXLXA0X2VHcC10LVdHUmFzVDQtYWlScTZKM3dPa054bFdjeF9NOVJzZ05CUmxqWlZiM2U0RUgyd2pieVIwTkcwUFVfOFJZNWZnSVhacFhIYjBOcHlqbF9BZw?oc=5","date":"2023-07-11","type":"trial","source":"appliedclinicaltrialsonline.com","summary":"Spontaneous Reporting System for Adverse Drug Reactions in Germany - appliedclinicaltrialsonline.com","headline":"Spontaneous Reporting System for Adverse Drug Reactions in Germany","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxONW80dWZ2TFJ6N0wtNzlnY0pjWFpCc1VSbWNaV3BiSXVYbGlHdy1rei1kWHVaRVl3NnFQUXpPMnBhT0lvQWhDMW9vMVp0aWtkTlBmSW9Vc0V5LVdPOEZ2OUdVNm8ybkNma1RDdU5KcHlxeVdaVFhIZ1hlODZtTWZIcFFCcV96YlE?oc=5","date":"2023-03-27","type":"regulatory","source":"pharmaphorum","summary":"Exploring the potential of FHIRs and e-labelling - pharmaphorum","headline":"Exploring the potential of FHIRs and e-labelling","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOQzl2TUNETlRLQUMyMnY2QXY4eldDaFZGYjBsNEtvSFVWRWtYVml6Szl5UGF5Tm96RXpWVERoMHJoVG83N2tPZW5vRm9SVjBiSVVPbkwwV1dHTlNHaDBpXzZONDVqeTZfNklZdGhIMEFwcW5Dc3dTZXhvX0M3MGVaOVROUzZUS1Jxd0xIVjBET05BdDFKMDJieFlEMUEycFRDTzZraHluX3VWRXlTU2M0eVNzRUprRThBM0VXeUU4aGNHWkk?oc=5","date":"2022-04-14","type":"pipeline","source":"BioSpectrum India","summary":"Latest trends for pharma & biotech companies in 2022: Navitas Life Sciences - BioSpectrum India","headline":"Latest trends for pharma & biotech companies in 2022: Navitas Life Sciences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNanFia3h0TEthd04yZUh6V01aTG0xcHpRTXFVSC04alJNdmkwMWwwOGFBODdFUWs5V09ncW1reXBpbkp0MW0ybExyUEs4S0ROQjV4MUF3elNFTUN3QVppMUVEc04ybDQ4RDBRdEluVE56Q013cFZoVGZzQnV5RWlmSmhDOGJpa0x4VDQxdlpGdklJbUdCQlJGblgyVEbSAaMBQVVfeXFMTnZBVnpJWHpMN1RZcE1lbXBlNTEtWm94RkxrQ0FSUVBhaWcySG1Mb201RW1RWmtqUnNjWWNHSFVuMWU3ZVp0cVFXZ2hCYUR2WGpFY1gwTHNkdDkyNUJoRTdwY1llWTFfbGZORzV3anVfY3ltUlI5a0hobEdlZUozaG9ZRXB5U2w5b05jUXgzZk10YjBLcWRwaEN2dkZpQlVQa0dMZw?oc=5","date":"2021-08-08","type":"pipeline","source":"Indian Pharma Post","summary":"TAKE divests stake in Navitas Life Sciences to HIG - Indian Pharma Post","headline":"TAKE divests stake in Navitas Life Sciences to HIG","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPczhIRm11T2FiRHJLRXI0dENiZG9XRURoZ3U5UHVOZWI3NmxPNnR6eEhxR3BSVkk2RjlFVkp5dUdCWGNjRjA2NjdZYld3TGpWT2pINmNFb3NRRnJxa092SkltMmp0T25wZ1BXNldhaFJocWgxMHZsZ1BGUElCLUNvd0tGLU5Ock1FYmxGZ19URGpTbnZIZTl5azRleV9famlWTjdFc2loUG1ZNGI2UHJ5YmVkaWVyN05YQ2c?oc=5","date":"2019-05-30","type":"trial","source":"Fierce Biotech","summary":"Navitas Life Sciences buys up KAI Research, adding to later-stage trial offerings - Fierce Biotech","headline":"Navitas Life Sciences buys up KAI Research, adding to later-stage trial offerings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNVXZjRnRFSG5UWVBfZUlmbHFZOC1oU0ctZWhLeWc3eVhmNkY3alMwVFlyYXJ5dDE2VDNERk5rN1R4UXBRM3JjUWVmZm9VcDd2aF9MV08wc2JQSHY2blhBZzVQdXBKUm5WUW1QS3NSTmFDNW8zTTBuem9zZW1CQnpmbTdMMG1kb3gwaVJPaWVWT29LeWpQZHlhdUlHcUplbW82Ync?oc=5","date":"2019-02-15","type":"trial","source":"New Jersey Business Magazine","summary":"Navitas Life Sciences Announces Acquisition of DataCeutics Inc. - New Jersey Business Magazine","headline":"Navitas Life Sciences Announces Acquisition of DataCeutics Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPWmFoS2J0cTJ6R3hXRkNDUExfMHJvc1I4aklkeXhfQklHdUdkSlAxRl9RRXlBVzNvMEp0THFTODZyX3BFbmU5MlJGeVBWT1ZIeGtwb0hZMVJxUU9GYUZPUFZzTkFwUG9iOEdoQTI1RzVWQnNqWlRZaTBPNkFHSFNpOVQ1MWFSMTdBODhpTHFMLWw3QjNvNkJrTFBRWVNKX0VGTm5pVzkxS24?oc=5","date":"2019-01-09","type":"pipeline","source":"PR Newswire","summary":"Navitas Life Sciences Strengthens Leadership Team - PR Newswire","headline":"Navitas Life Sciences Strengthens Leadership Team","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxORHUtQ2c5UTNJNVVfNl9xclZqS2M3Sks5RFVyU3M1dURXNklMYTlYM1NwTE9GNWNaTDRMeF84VkxBREF2ZGRSM0dzSEdmRF9JYWhENEdIS21XcWdtX2NmUFEtVWk0NEZNZW1mSkNuX1pjc1lHS2RyN3MyS2dmNjh6Z1pNck5qMERYbXNJazYwdDZtUGRzZVNKNU00QjNvemJ3UUh6NkFVa1VVbWJucHV2T2dCSkpSRTY1QmdVN0ppZFJxVG1WcmFLZFA1LW15U2M1X2FueHVsdk0zQ0hHV0RVT2JPUTkxQzc0THJvcThzeFM3Sk91RUQzUUk2THhQWUow?oc=5","date":"2016-10-17","type":"pipeline","source":"The E’ville Eye","summary":"E'ville Biz: Novartis shifting Pharma jobs to Emeryville Campus, Zymergen raises $130MM, Ex'pression College becomes SAE - The E’ville Eye","headline":"E'ville Biz: Novartis shifting Pharma jobs to Emeryville Campus, Zymergen raises $130MM, Ex'pression College becomes SAE","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}